Menu Back toSession 6 Track 3: The Art of Medical Science Liaising – How is the Canvas Changing

Medical Affairs and Scientific Communications Forum

DIA Your Way! Join us live in-person or live from the comfort of your home/office. This event offers two learning avenues depending on your preference!

Session 6 Track 3: The Art of Medical Science Liaising – How is the Canvas Changing

Session Chair(s)

J. Lynn  Bass, PharmD, RPh

J. Lynn Bass, PharmD, RPh

  • Senior Director and Head, Medical Science Directors
  • Medexus Pharma, United States
Donna  Booth, PharmD

Donna Booth, PharmD

  • Head, Field Medical Accounts-East, US Medical Affairs
  • GlaxoSmithKline, United States
The field based medical affairs teams serve as conduits of medical and scientific information and are positioned at the heart of pharma’s network of thought leaders and other experts. However, it has been difficult to realize the true impact of their field activities. In this session, we will evaluate the impact of two specific areas of interest - through expanding career opportunities for individuals along with expanding the base of customer segments. Each of these will provide insight into future methods to assess impact of these important roles.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe new and expanded customer segments for field medical affairs
  • Examine the impact and value to the company resulting from interactions with these new customer segments
  • Review potential career paths for field medical affairs and how this career path adds value to both the individual and the company


Jeff  Vaughan, PharmD, MS


Jeff Vaughan, PharmD, MS

  • National Director, Field Medical Science
  • Ashfield Engage, United States
Rachel  Couchenour, PharmD, MBA


Rachel Couchenour, PharmD, MBA

  • VP, Head of Medical Affairs
  • Travere Therapeutics, United States